Patent ID: 8790869

Claim:
A method of identifying a renal tumor biomarker, comprising: obtaining a peripheral biological fluid sample from a subject with a renal tumor; obtaining a renal tumor tissue sample and an adjacent non-tumor tissue sample from the subject with the renal tumor; extracting proteins from the peripheral biological fluid sample, renal tumor tissue sample and the adjacent non-tumor tissue sample generating a peripheral biological fluid sample protein extract, a renal tumor tissue sample protein extract and an adjacent non-tumor tissue sample protein extract; depleting proteins from the peripheral biological fluid sample protein extract, the renal tumor tissue sample protein extract and the adjacent non-tumor tissue sample protein extract generating a depleted biological fluid protein sample, a depleted renal tumor tissue protein sample and a depleted adjacent non-tumor tissue protein sample; digesting the depleted biological fluid protein sample, the depleted renal tumor tissue protein sample and the depleted adjacent non-tumor tissue protein sample generating a digested biological fluid protein sample, a digested depleted renal tumor tissue protein sample and a digested adjacent non-tumor tissue protein sample; fractionating the digested biological fluid protein sample, the digested depleted renal tumor tissue protein sample and the digested adjacent non-tumor tissue protein sample generating a fractionated biological fluid protein sample, a fractionated depleted renal tumor tissue protein sample and a fractionated adjacent non-tumor tissue protein sample; detecting a protein expression profile in the fractioned peripheral biological fluid protein sample, the fractioned renal tumor tissue protein sample and the fractionated adjacent non-tumor tissue protein sample by performing high mass accuracy nano-flow reversed phase liquid chromatography-electrospray ionization-linear ion trap-Fourier transform ion cyclotron resonance-mass spectrometry (nfRPLC-ESI-LIT-FTICR-MS) mass spectrometry generating a peripheral biological fluid mass spectra, a renal tumor tissue mass spectra and an adjacent non-tumor tissue mass spectra; and by a computer, analyzing the peripheral biological fluid mass spectra, the renal tumor tissue mass spectra and the adjacent non-tumor tissue mass spectra, generating a peripheral biological fluid protein profile, a renal tumor tissue protein profile and an adjacent non-tumor tissue protein profile; identifying a renal tumor marker by performing subtractive proteomics comprising identifying a renal tumor tissue specific subset of proteins by comparing the renal tumor tissue protein profile to the adjacent non-tumor tissue protein profile; and comparing the renal tumor tissue specific subset of proteins with proteins within the peripheral biological fluid protein profile, wherein a renal tumor marker is a protein detected in both the renal tumor tissue specific subset of proteins and the peripheral biological fluid profile.